ManRos™ Reagents - Lead Compounds for Drug Discovery

ManRos™ Therapeutics (MRT) and Adipogen International, Inc. entered into a worldwide exclusive marketing and sales agreement to commercialize MRT's small molecule lead compounds and supporting reagents for drug development under the brand name ManRos™ Reagents.

The aim of ManRos™ Reagents is supplying potent pharmacological inhibitors of selected protein kinases against targeted diseases to the research market. ManRos™ focuses on cell cycle research, signal transduction, neuroprotection, stroke, brain trauma, cystic fibrosis and unicellular parasites research. All reagents are originally based on natural products.

Product Flyer